
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79468 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Propylene glycol ester of Azelaic acid Impurity
Formula:C12H22O5C12H22O5Molecular weight:246.30 : 246.30NAB-14
CAS:<p>NAB-14: non-competitive GluN2C/D antagonist, IC50 580 nM for GluN1/2D, >800x selectivity over GluN2A/B, blood-brain-barrier penetrant.</p>Formula:C20H21N3O3Color and Shape:SolidMolecular weight:351.4(Rac)-NMDAR antagonist 1
CAS:<p>(Rac)-NMDAR antagonist 1 is a racemate of NMDAR antagonist 1. NMDAR antagonist 1 is a potent, orally active, NR2B-selective NMDAR antagonist.</p>Formula:C20H20BrN3O2Color and Shape:SolidMolecular weight:414.3Lanicemine
CAS:<p>Lanicemine is a low-trapping NMDA channel blocker. It also has a binding (Ki: 0.56-2.1 μM).</p>Formula:C13H14N2Purity:98%Color and Shape:SolidMolecular weight:198.26LY 233053
CAS:<p>LY 233053 is a Competitive NMDA receptor antagonist.</p>Formula:C8H13N5O2Purity:98%Color and Shape:SolidMolecular weight:211.22NMDA-IN-2
CAS:<p>NMDA-IN-2 (compound 6b) is a Procaine derivative that is an inhibitor of NMDA receptor 2B subtype [1].</p>Formula:C15H22N2O3Color and Shape:SolidMolecular weight:278.35

